CoChat
Sign Up
Cited by 96Advancements in Transdermal Drug DeliveryNanoparticle-Based Drug DeliveryAdvanced Drug Delivery Systems

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

In vitro and in vivo characterization of pharmaceutical topical nanocarriers containing anticancer drugs for skin cancer treatment

Gupta, Vandana, Trivedi, Piyush·2018·Lipid Nanocarriers for Drug Targeting
DOI 10.1016/b978-0-12-813687-4.00015-3
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/b978-0-12-813687-4.00015-3

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 5 references

Research works printed but not linked: 253

  1. Abdel-Mottaleb, 2011, Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I, Drug Dev. Ind. Pharm., 37, 178, 10.3109/03639045.2010.502534 · DOI
  2. Abdulkarim, 2010, Topical piroxicam in vitro release and in vivo anti-inflammatory and analgesic effects from palm oil esters-based nanocream, Int. J. Nanomed., 5, 915, 10.2147/IJN.S13305 · DOI
  3. Abraham, 1992, Lamellar structures formed by stratum corneum lipids in vitro: a deuterium nuclear magnetic resonance (NMR) study, Pharm Res., 9, 1415, 10.1023/A:1015802711440 · DOI
  4. Adolfina, 2008, Vesicular lipidic systems, liposomes, PLO, and liposomes–PLO: characterization by electronic transmission microscopy, Drug Dev. Ind. Pharm., 34, 1269, 10.1080/03639040802026095 · DOI
  5. Agarwal, 2010, Important elements for the diagnosis of drug-induced liver injury, Clin. Gastroenterol. Hepatol., 8, 463, 10.1016/j.cgh.2010.02.008 · DOI
  6. Ahaghotu, 2005, Effect of methyl substitution of benzene on the percutaneous absorption and skin irritation in hairless rats, Toxicol. Lett., 159, 261, 10.1016/j.toxlet.2005.05.020 · DOI
  7. Ajima, 2015, Spectrophotometric determination of acyclovir after its reaction with ninhydrin and ascorbic acid, J. App. Pharm. Sci., 5, 065, 10.7324/JAPS.2015.50411 · DOI
  8. Alhaique, 2016, From macro to nano polysaccharide hydrogels: an opportunity for the delivery of drugs, J. Drug Deliv. Sci. Technol., 32, 88, 10.1016/j.jddst.2015.09.018 · DOI
  9. Alhareth, 2012, HPLC quantification of doxorubicin in plasma and tissues of rats treated with doxorubicin loaded poly(alkylcyanoacrylate) nanoparticles, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 1, 128, 10.1016/j.jchromb.2012.01.025 · DOI
  10. Al-Khamis, 1986, Microviscosity and drug release from topical gel formulations, Parma. Res., 3, 214, 10.1023/A:1016386613239 · DOI
  11. Ashara, 2014, Micro-emulsion based emulgel: a novel topical drug delivery system, Asian Pac. J. Trop. Dis., 4, S27, 10.1016/S2222-1808(14)60411-4 · DOI
  12. Aslam, 2016, Application of Box–Behnken design for preparation of glibenclamide loaded lipid based nanoparticles: optimization, in vitro skin permeation, drug release and in vivo pharmacokinetic study, J. Mol. Liq., 219, 897, 10.1016/j.molliq.2016.03.069 · DOI
  13. Attari, 2016, Formulation and characterisation of nanosuspensions of BCS class II and IV drugs by combinative method, J. Exp. Nano., 11, 276, 10.1080/17458080.2015.1055841 · DOI
  14. Avgoustakis, 2002, PLGA–mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties, J. Control. Release, 79, 123, 10.1016/S0168-3659(01)00530-2 · DOI
  15. Baca-Estrada, 2000, Intranasal immunization with liposome formulated yersinia pestis vaccine enhances mucosal immune responses, Vaccine, 18, 2203, 10.1016/S0264-410X(00)00019-0 · DOI
  16. Bai, 2011, Carboxymethylchitosan-coated proliposomes containing coix seed oil: characterisation, stability and in vitro release evaluation, Food Chem., 129, 1695, 10.1016/j.foodchem.2011.06.033 · DOI
  17. Banyard, 2013, Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model, Sci. Rep., 3, 3151, 10.1038/srep03151 · DOI
  18. Bao, 2004, Direct 99mTc labeling of pegylated liposomal doxorubicin (Doxil) for pharmacokinetic and noninvasive imaging studies, J. Pharmacol. Exp. Ther., 308, 419, 10.1124/jpet.103.059535 · DOI
  19. Barbero, 2009, Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review, Toxicol. In Vitro, 23, 1, 10.1016/j.tiv.2008.10.008 · DOI
  20. Barot, 2012, Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using D-optimal design, AAPS PharmSciTech., 13, 184, 10.1208/s12249-011-9742-7 · DOI
  21. Barral, 2010, In vivo high resolution magnetic resonance skin imaging at 1.5 T and 3 T, Man. Reson. Med., 63, 790, 10.1002/mrm.22271 · DOI
  22. Baruah, 2012, Interaction of liposome-encapsulated cisplatin with biomolecules, J. Biol. Inorg. Chem., 17, 899, 10.1007/s00775-012-0907-y · DOI
  23. Batheja, 2011, Topical drug delivery by a polymeric nanosphere gel: formulation optimization and in vitro and in vivo skin distribution studies, J. Control. Release, 149, 159, 10.1016/j.jconrel.2010.10.005 · DOI
  24. Beck-Broichsitter, 2011, Biophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitro, Nanomed. Nanotechnol., 7, 341, 10.1016/j.nano.2010.10.007 · DOI
  25. Beloqui, 2016, Nanostructured lipid carriers: promising drug delivery systems for future clinics, Nanomed. Nanotechnol. Biol. Med., 12, 143, 10.1016/j.nano.2015.09.004 · DOI
  26. Beriro, 2016, A review of the current state of the art of physiologically-based tests for measuring human dermal in vitro bioavailability of polycyclic aromatic hydrocarbons (PAH) in soil, J. Hazard. Mater., 305, 240, 10.1016/j.jhazmat.2015.11.010 · DOI
  27. Bhardwaj, 2010, A novel USP apparatus 4 based release testing method for dispersed systems, Int. J. Pharm., 388, 287, 10.1016/j.ijpharm.2010.01.009 · DOI
  28. Bhatia, 2012, Tamoxifen-loaded novel liposomal formulations: evaluation of anticancer activity on DMBA-TPA induced mouse skin carcinogenesis, J. Drug Target., 20, 544, 10.3109/1061186X.2012.694887 · DOI
  29. Bjornsson, 2016, Categorization of drugs implicated in causing liver injury: critical assessment based upon published case reports, Hepatology, 63, 590, 10.1002/hep.28323 · DOI · Paper page
  30. Bodde, 1990, Freeze fracture electron microscopy of in vitro reconstructed human epidermis, J. Invest. Dermatol., 95, 108, 10.1111/1523-1747.ep12874082 · DOI
  31. Bolzinger, 2012, Penetration of drugs through skin, a complex rate-controlling membrane, Curr. Opin. Colloid Interface Sci., 17, 156, 10.1016/j.cocis.2012.02.001 · DOI
  32. Boyle, 2004, Cancer of the skin: a forgotten problem in Europe, Ann. Oncol., 15, 5, 10.1093/annonc/mdh032 · DOI
  33. Brenner, 1993, Topical tretinoin treatment in basal cell carcinoma, J. Dermatol. Surg. Oncol., 19, 264, 10.1111/j.1524-4725.1993.tb00346.x · DOI
  34. Burks, 2011, Clearance and biodistribution of liposomally encapsulated nitroxides: a model for targeted delivery of electron paramagnetic resonance imaging probes to tumors, Drug Metab. Dispos., 39, 1961, 10.1124/dmd.111.039636 · DOI
  35. Calvo, 1996, Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers, J. Pharm. Sci., 85, 530, 10.1021/js950474+ · DOI
  36. Calzavara-Pinton, 2008, Reflectance confocal microscopy for in vivo skin imaging, Photochem. Photobiol., 84, 1421, 10.1111/j.1751-1097.2008.00443.x · DOI
  37. Campanini, 2013, Efficacy of topical formulations containing Pimenta pseudocaryophyllus extract against UVB-induced oxidative stress and inflammation in hairless mice, J. Photochem. Photobiol. B: Biol., 127, 153, 10.1016/j.jphotobiol.2013.08.007 · DOI
  38. Caputo, 2016, Fractional derivatives in the transport of drugs across biological materials and human skin, Phys. A, 462, 705, 10.1016/j.physa.2016.06.135 · DOI
  39. Cereda, 2013, Transdermal delivery of butamben using elastic and conventional liposomes, J. Liposome Res., 23, 228, 10.3109/08982104.2013.796975 · DOI
  40. Cevc, 1992, Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force, Biochim. Biophys. Acta, 1004, 226, 10.1016/0005-2736(92)90154-E · DOI
  41. Cevc, 2003, Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier, Biophys. J., 84, 1010, 10.1016/S0006-3495(03)74917-0 · DOI
  42. Cevc, 1997, Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo, J. Control. Release, 45, 211, 10.1016/S0168-3659(96)01566-0 · DOI
  43. Cevc, 1998, Ultraflexible vesicles, Transfersomes, have an ex- tremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin, Biochim. Biophys. Acta Biomembr., 1368, 201, 10.1016/S0005-2736(97)00177-6 · DOI
  44. Chawla, 2012, Rheological studies on solid lipid nanoparticle based carbopol gels of aceclofenac, Coll. Surf. B: Biointerfaces, 92, 293, 10.1016/j.colsurfb.2011.12.006 · DOI
  45. Chen, 2013, Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique, Drug Dev. Ind. Pharm., 39, 20, 10.3109/03639045.2011.650648 · DOI
  46. Chen-yu, 2012, Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery, Int. J. Pharm., 430, 292, 10.1016/j.ijpharm.2012.03.042 · DOI
  47. Chidambaram, 1999, A novel in vitro release method for submicron sized dispersed systems, AAPS PharmSci., 1, 32, 10.1208/ps010311 · DOI
  48. Choi, 2012, Use of macrophages to deliver therapeutic and imaging contrast agents to tumors, Biomaterials, 33, 4195, 10.1016/j.biomaterials.2012.02.022 · DOI
  49. Chudasama, 2011, Investigation of microemulsion system for transdermal delivery of itraconazole, J. Adv. Pharm. Technol. Res., 2, 30, 10.4103/2231-4040.79802 · DOI
  50. Clarke, 2012, Nonmelanoma skin cancers: treatment options, Aust. Fam. Physician, 41, 476
  51. Contente, 2014, Association of daunorubicin to a lipid nanoemulsion that binds to low-density lipoprotein receptors enhances the antitumour action and decreases the toxicity of the drug in melanoma-bearing mice, J. Pharm. Pharmacol., 66, 1698, 10.1111/jphp.12296 · DOI
  52. Contreras, 2001, Rheological characterization of hydroalcoholic gels—15% ethanol—of Carbopol® Ultrez™ 10 Il, Farmaco, 56, 437, 10.1016/S0014-827X(01)01057-6 · DOI
  53. Cook, 2012, Predictive in vivo animal models and translation to clinical trials, Drug Discov. Today, 17, 253, 10.1016/j.drudis.2012.02.003 · DOI
  54. Craig, 2012, Cisplatin-tethered gold nanoparticles that exhibit enhanced reproducibility, drug loading, and stability: a step closer to pharmaceutical approval?, Inorg. Chem., 51, 3490, 10.1021/ic202197g · DOI
  55. Davids, 2010, Combating melanoma: the use of photodynamic therapy as a novel, adjuvant therapeutic tool, Cancer Treatment Rev., 10.1016/j.ctrv.2010.11.007 · DOI
  56. Deli, 2009, Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery, Biochim. Biophys. Acta (BBA) Biomembr., 1788, 892, 10.1016/j.bbamem.2008.09.016 · DOI
  57. Dhiman, 2008, Formulation, characterization, and in vitro evaluation of bioadhesive gels containing 5-fluorouracil, Pharm. Dev. Technol., 13, 15, 10.1080/10837450701702438 · DOI
  58. Diepgen, 2002, The epidemiology of skin cancer, Br. J. Dermatol., 146, 1, 10.1046/j.1365-2133.146.s61.2.x · DOI
  59. Ding, 2012, Image guided biodistribution and pharmacokinetic studies of theranostics, Theranostics, 2, 1040, 10.7150/thno.4652 · DOI
  60. Dolatabadi, 2014, Formulation, characterization and cytotoxicity studies of alendronate sodium-loaded solid lipid nanoparticles, Colloids Surf. B: Biointerfaces, 117, 21, 10.1016/j.colsurfb.2014.01.055 · DOI
  61. D’Souza, 2014, A review of in vitro drug release test methods for nano-sized dosage forms, Adv. Pharm
  62. D’Souza, 2006, Methods to assess in vitro drug release from injectable polymeric particulate systems, Pharm. Res., 23, 460, 10.1007/s11095-005-9397-8 · DOI
  63. Egbaria, 1991, Topical application of liposomal preparations, Cosmet. Toilet., 106, 79
  64. El-Nabarawi, 2013, Transdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailability, Int. J. Pharm., 443, 307, 10.1016/j.ijpharm.2013.01.016 · DOI
  65. Elnaggar, 2014, Lecithin-based nanostructured gels for skin delivery: an update on state of art and recent applications, J. Control. Release, 180, 10, 10.1016/j.jconrel.2014.02.004 · DOI
  66. Fabin, 1972, Localization of lipophilic molecules penetrating rat skin in vivo by quantitative autoradiography, Dermatology, 84, 117
  67. Fang, 2008, Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC), Eur. J. Pharm. Biopharm., 70, 633, 10.1016/j.ejpb.2008.05.008 · DOI
  68. Ferreira, 2011, Risk factors for nonmelanoma skin cancer in Taubate, Sao Paulo, Brazil: a case–control study, Rev. Assoc. Med. Bras., 57, 424, 10.1016/S0104-4230(11)70089-6 · DOI
  69. Fesq, 2000, Improved risk-benefit ratio for a triamcinolone acetonide Transfersome (R) formulation in comparison to a commercial triamcinolone acetonide formulation, J. Invest. Dermatol., 115, 590
  70. Flaherty, 2012, Targeting metastatic melanoma, Annu. Rev. Med., 63, 171, 10.1146/annurev-med-050410-105655 · DOI
  71. Flaherty, 2010, Inhibition of mutated, activated BRAF in metastatic melanoma, N. Engl. J. Med., 363, 809, 10.1056/NEJMoa1002011 · DOI · Paper page
  72. Flaten, 2015, In vitro skin models as a tool in optimization of drug formulation, Eur. J. Pharm. Sci., 75, 10, 10.1016/j.ejps.2015.02.018 · DOI
  73. Foldvari, 1994, In vitro cutaneous and percutaneous delivery and in vivo efficacy of tetracaine from liposomal and conventional vehicles, Pharm. Res., 11, 1593, 10.1023/A:1018909821048 · DOI
  74. Foldvari, 1997, Clinical observations with topical liposome encapsulated interferon alpha for the treatment of genital papillomavirus infections, J. Liposome Res., 7, 115, 10.3109/08982109709035489 · DOI
  75. Foldvari, 1999, Dermal and transdermal delivery of protein pharmaceuticals lipid-based delivery systems for interferon alpha, Biotechnol. Appl. Biochem., 30, 129, 10.1111/j.1470-8744.1999.tb00903.x · DOI
  76. Foldvari, 1999, Transdermal delivery of therapeutic proteins through human skin in vivo: interferon alpha as a model, Proc. Intl. Symp. Control. Rel. Bioact. Mater., 26, 469
  77. Fouad, 2013, Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation, Int. J. Pharm., 453, 569, 10.1016/j.ijpharm.2013.06.009 · DOI
  78. Freedberg, 2004, Book Reviews-Fitzpatrick's Dermatology in general medicine, J. Am. Acad. Dermatol., 51, 325, 10.1016/j.jaad.2003.12.039 · DOI
  79. Gambichler, 2015, Recent advances in clinical application of optical coherence tomography of human skin, Clin. Cosmet. Investig. Dermatol., 7, 345, 10.2147/CCID.S69119 · DOI
  80. Gay, 1994, Characterization of low temperature (i.e., < 65 degrees C) lipid transitions in human stratum corneum, J. Invest. Dermatol., 103, 233, 10.1111/1523-1747.ep12393214 · DOI
  81. Gibbs, 2001, Medical management of cutaneous malignancies, Clin. Dermatol., 19, 298, 10.1016/S0738-081X(01)00173-0 · DOI
  82. Gloster, 2006, Skin cancer in skin of color, J. Am. Acad. Dermatol., 55, 741, 10.1016/j.jaad.2005.08.063 · DOI · Paper page
  83. Gonzalez, 2001, Real-time evidence of in vivo leukocyte trafficking in human skin by reflectance confocal microscopy, J. Invest. Dermatol., 117, 384, 10.1046/j.0022-202x.2001.01420.x · DOI
  84. Gordon, 2013, Skin cancer: an overview of epidemiology and risk factors, Sem. Ooncol. Nurs., 29, 160, 10.1016/j.soncn.2013.06.002 · DOI
  85. Grazú, 2012, Nanocarriers as nanomedicines: design concepts and recent advances, Front. Nanosci., 4, 337, 10.1016/B978-0-12-415769-9.00014-5 · DOI
  86. Guo, 2012, Development of a Quercetin-loaded nanostructured lipid carrier formulation for topical delivery, Int. J. Pharm., 430, 292, 10.1016/j.ijpharm.2012.03.042 · DOI
  87. Gupta, 2012, Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis, Chem. Res. Lipids, 165, 454, 10.1016/j.chemphyslip.2012.01.006 · DOI
  88. Gupta, 2010, Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis, J. Liposome Res., 20, 341, 10.3109/08982101003596125 · DOI
  89. Gupta, 2011, Reduction in cisplatin genotoxicity (micronucleus formation) in non target cells of mice by protransfersome gel formulation used for management of cutaneous squamous cell carcinoma, Acta Pharm., 61, 63, 10.2478/v10007-011-0004-8 · DOI
  90. Harush-Frenkel, 2010, A safety and tolerability study of differently-charged nanoparticles for local pulmonary drug delivery, Toxicol. Appl. Pharm., 246, 83, 10.1016/j.taap.2010.04.011 · DOI
  91. Hendriks, 2011, Sensitive DsRed fluorescence-based reporter cell systems for genotoxicity and oxidative stress assessment, Mutat. Res., 709–710, 49, 10.1016/j.mrfmmm.2011.02.013 · DOI
  92. Heng, 2008, What is a suitable dissolution method for drug nanoparticles?, Pharm Res., 25, 1696, 10.1007/s11095-008-9560-0 · DOI
  93. Hengge, 2006, Adverse effects of topical glucocorticosteroids, J. Am. Acad. Dermatol., 54, 1, 10.1016/j.jaad.2005.01.010 · DOI
  94. Ho, 2012, Blood vessel hyperpermeability and pathophysiology in human tumour xenograft models of breast cancer; a comparison of ectopic and orthotopic tumours, BMC Cancer, 12, 579, 10.1186/1471-2407-12-579 · DOI
  95. Hodi, 2008, CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS, Nat. Clin. Pract. Oncol., 5, 557, 10.1038/ncponc1183 · DOI
  96. Hodi, 2010, Improved survival with ipilimumab in patients with metastatic melanoma, N. Engl. J. Med., 363, 711, 10.1056/NEJMoa1003466 · DOI · Paper page
  97. Hodoroaba, 2014, Inspection of morphology and elemental imaging of single nanoparticles by highresolution SEM/EDX in transmission mode, Surf. Interface Anal., 46, 945, 10.1002/sia.5426 · DOI
  98. Hoey, 2007, Skin cancer trends in Northern Ireland and consequences for provision of dermatology services, Br. J. Dermatol., 156, 1301, 10.1111/j.1365-2133.2007.07936.x · DOI
  99. Holman, 1990, An optimized freeze-fracture replication procedure for human skin, J. Invest. Dermatol., 94, 332, 10.1111/1523-1747.ep12874462 · DOI
  100. Honary, 2013, Effect of zeta potential on the properties of nano-drug delivery systems—a review (part 1), Trop. J. Pharm. Res., 12, 255
  101. Honary, 2013, Effect of zeta potential on the properties of nano-drug delivery systems—a review (part 2), Trop. J. Pharm. Res., 12, 265
  102. Ishida, 2015, Impact of humidity on in vitro human skin permeation experiments for predicting in vivo permeability, J. Pharm. Sci., 104, 4223, 10.1002/jps.24656 · DOI
  103. Jain, 2003, Transfersomes-A novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation, Drug Dev. Ind. Pharm., 29, 1013, 10.1081/DDC-120025458 · DOI
  104. Jain, 2006, Sustained and targeted delivery of an anti-HIV agent using elastic liposomal formulation: mechanism of action, Curr. Dug Deliv., 3, 157, 10.2174/156720106776359221 · DOI
  105. Ji, 2012, Targeting the RAS pathway in melanoma, Trends Mol. Med., 18, 27, 10.1016/j.molmed.2011.08.001 · DOI
  106. Jones, 2009, In vitro assessments of nanomaterial toxicity, Adv. Drug Deliv. Rev., 61, 438, 10.1016/j.addr.2009.03.005 · DOI
  107. Jun, 2015, Recent advances in targeted nanoparticles drug delivery to melanoma, Nanomed: Nanotechnol. Biol. Med., 11, 769, 10.1016/j.nano.2014.11.006 · DOI
  108. Jung, 2014, Human tumor xenograft models for preclinical assessment of anticancer drug development, Toxicol. Res., 30, 1, 10.5487/TR.2014.30.1.001 · DOI
  109. Jung, 2012, Polymeric nanoparticles containing taxanes enhance chemoradiotherapeutic efficacy in nonsmall cell lung cancer, Int. J. Radiat. Oncol. Biol. Phys., 84, 77, 10.1016/j.ijrobp.2012.02.030 · DOI
  110. Kalpana, 2010, Challenges and opportunities in dermal/transdermal delivery, Ther. Deliv., 1, 109, 10.4155/tde.10.16 · DOI
  111. Kalra, 2007, Effect of cimetidine on hepatoxicity induced by isoniazid-rifampicin combination in rabbits, Ind. J. Gasteronenterol., 26, 18
  112. Kamath, 2012, Pharmacokinetics and biodistribution of a human monoclonal antibody to oxidized LDL in Cynomolgus monkey using PET imaging, PLoS One, 7, e45116, 10.1371/journal.pone.0045116 · DOI
  113. Karie, 2010, Toxicite renale des, medicaments, Néphrologie Thérapeutique, 6, 58, 10.1016/j.nephro.2009.02.006 · DOI
  114. Katarzyna, 2016, Biomaterial-based regional chemotherapy: local anticancer drug delivery to enhance chemotherapy and minimize its side-effects, Mat. Sci. Eng. C, 62, 927, 10.1016/j.msec.2016.01.063 · DOI
  115. Katsambas, 2004, Acne: systemic treatment, Clin. Dermatol., 22, 412, 10.1016/j.clindermatol.2004.03.014 · DOI
  116. Kawadkar, 2013, Formulation, characterization and in vitro– in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery, Drug Dev. Ind. Pharm., 39, 569, 10.3109/03639045.2012.686509 · DOI
  117. Kilfoyle, 2012, Development of paclitaxel-TyroSpheres for topical skin treatment, J. Control. Release, 163, 18, 10.1016/j.jconrel.2012.06.021 · DOI
  118. Klimich, 1986, Use of Fourier transforms infrared spectroscopy with alternate total reflectance for in vivo quantification of polydimethylsiloxanes on human skin, J. Soc. Cosmet. Chem., 37, 73
  119. Kong, 2011, Characterization of porcine skin as a model for human skin studies using infrared spectroscopic imaging, Analyst, 136, 2359, 10.1039/c1an15111h · DOI
  120. Kumar, 2011, In vitro and in vivo study of indomethacin loaded gelatin nanoparticles, J. Biomed. Nanotechnol., 7, 325, 10.1166/jbn.2011.1290 · DOI
  121. Kunjachan, 2015, Noninvasive imaging of nanomedicines and nanotheranostics: principles, progress and prospects, Chem. Rev., 115, 10907, 10.1021/cr500314d · DOI
  122. Lademann, 2012, Noninvasive analysis of penetration and storage of isoconazole nitrate in the stratum corneum and the hair follicles, Eur. J. Pharm. Biopharm., 80, 615, 10.1016/j.ejpb.2011.12.013 · DOI
  123. Lau, 2003, Entrapment of bleomycin in ultra-deformable liposomes, STP Pharma Sci., 13, 237
  124. Lee, 2007, Evaluation of physicochemical properties, skin permeation and accumulation profiles of ketolorac fatty ester prodrugs, Biol. Pharm. Bull., 30, 2211, 10.1248/bpb.30.2211 · DOI
  125. Leiter, 2008, Epidemiology of melanoma and nonmelanoma skin cancer—the role of sunlight, Adv. Exp. Med. Biol., 624, 89, 10.1007/978-0-387-77574-6_8 · DOI
  126. Lemoine, 1996, Stability study of nanoparticles of poly (epsilon-caprolactone), poly (D, L-lactide) and poly (D, L-lactide-co-glycolide), Biomaterials, 17, 2191, 10.1016/0142-9612(96)00049-X · DOI
  127. Levy, 1990, Drug release from submicronized o/w emulsion: a new in vitro kinetic evaluation model, Int. J. Pharm., 66, 29, 10.1016/0378-5173(90)90381-D · DOI
  128. Liang, 2005, Effect of chain lengths of PEO–PPO–PEO on small unilamellar liposome morphology and stability: an AFM investigation, J. Colloid Inter. Sci., 285, 360, 10.1016/j.jcis.2004.11.042 · DOI
  129. Lipozenčić, 2014, Perioral dermatitis, Clin. Dermatol., 32, 125, 10.1016/j.clindermatol.2013.05.034 · DOI
  130. Liu, 2007, Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery, Int. J. Pharm., 328, 191, 10.1016/j.ijpharm.2006.08.007 · DOI
  131. Lomas, 2012, A systematic review of worldwide incidence of nonmelanoma skin cancer, Br. J. Dermatol., 166, 1069, 10.1111/j.1365-2133.2012.10830.x · DOI
  132. Lopez, 2004, Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters, Adv. Drug Deliv. Rev., 56, 77, 10.1016/j.addr.2003.09.002 · DOI
  133. López-Dávila, 2012, Organic nanocarriers for cancer drug delivery, Curr. Opin. Pharmacol., 12, 414, 10.1016/j.coph.2012.02.011 · DOI
  134. Luo, 2016, A comparative study of the in vitro permeation of ibuprofen in mammalian skin, the PAMPA model and silicone membrane, Int. J. Pharm., 505, 14, 10.1016/j.ijpharm.2016.03.043 · DOI · Paper page
  135. Madan, 2010, Nonmelanoma skin cancer, The Lancet., 375, 673, 10.1016/S0140-6736(09)61196-X · DOI
  136. Maekawa, 2002, Inhibition of cervical lymph node metastasis by marimastat (BB-2516) in an orthotopic oral squamous cell carcinoma implantation model, Clin. Exp. Metastasis, 19, 513, 10.1023/A:1020329411957 · DOI
  137. Manchun, 2012, Targeted therapy for cancer using pH-responsive nanocarrier systems, Life Sci., 90, 381, 10.1016/j.lfs.2012.01.008 · DOI
  138. Manconi, 2006, Niosomes as carriers for tretinoin: III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin, Int. J. Pharm., 311, 11, 10.1016/j.ijpharm.2005.11.045 · DOI
  139. Manconi, 2011, Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle–skin interaction, Eur. J. Pharm. Biopharm., 78, 27, 10.1016/j.ejpb.2010.12.010 · DOI
  140. Mangalathillam, 2012, Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route, Nanoscale, 4, 239, 10.1039/C1NR11271F · DOI
  141. Manosroi, 2004, Stability and transdermal absorption of topical amphotericin B liposome formulations, Int. J. Pharm., 270, 279, 10.1016/j.ijpharm.2003.10.031 · DOI
  142. Mao, 2016, Thermosensitive hydrogel system with paclitaxel liposomes used in localized drug delivery system for in situ treatment of tumor: better antitumor efficacy and lower toxicity, J. Pharm. Sci., 105, 194, 10.1002/jps.24693 · DOI
  143. Marepally, 2014, Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques, Nanomedicine, 9, 2157, 10.2217/nnm.13.202 · DOI
  144. Marinescu, 2010, Experimental model of chemically induced skin carcinogenesis in mice, Rev. Rom. Med. Vet., 20, 97
  145. Martinez, 2001, The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician, Mayo Clin. Proceed., 76, 1253, 10.4065/76.12.1253 · DOI
  146. Maryam, 2010, Protective effects of silymarin in isoniazid induced hepatotoxicity in rabbits, Ann. King Edw. Med. Univ., 16, 43
  147. Mezei, 1980, Liposomes-A selective drug delivery system for the topical route of administration I. Lotion dosage form, Life Sci., 26, 1473, 10.1016/0024-3205(80)90268-4 · DOI
  148. Mir, 1998, Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy, Br. J. Cancer, 77, 2336, 10.1038/bjc.1998.388 · DOI
  149. Mishra, 2007, Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride, J. Pharm. Sci., 96, 145, 10.1002/jps.20737 · DOI
  150. Mlosek, 2013, The use of high frequency ultrasound imaging in skin moisturization measurement, Skin Res. Technol., 19, 169, 10.1111/srt.12029 · DOI
  151. Modi, 2012, Transfersomes: new dominants for transdermal drug delivery, Am. J. PharmTech. Res., 2, 71
  152. Moghassemi, 2014, Nano-niosomes as nanoscale drug delivery systems: an illustrated review, J. Control. Release, 185, 22, 10.1016/j.jconrel.2014.04.015 · DOI
  153. Mojumdar, 2016, Stratum corneum lipid matrix: location of acyl ceramide and cholesterol in the unit cell of the long periodicity phase, BBA—Biomembranes, 1858, 1926, 10.1016/j.bbamem.2016.05.006 · DOI
  154. Montenegro, 2016, From nanoemulsions to nanostructured lipid carriers: A relevant development in dermal delivery of drugs and cosmetics, J. Drug Deliv. Sci. Technol., 32, 100, 10.1016/j.jddst.2015.10.003 · DOI
  155. Moore, 2013, Can acute dermal systemic toxicity tests be replaced with oral tests? A comparison of route-specific systemic toxicity and hazard classifications under the globally harmonized system of classification and labelling of chemicals (GHS), Regul. Toxicol. Pharmacol., 66, 30, 10.1016/j.yrtph.2013.02.005 · DOI
  156. Moro, 2012, Patient-derived xenografts of non small cell lung cancer; resurgence of an old model for investigation of modern concepts of tailored therapy and cancer stem cells, J. Biomed. Biotechnol., 2012, 1, 10.1155/2012/568567 · DOI
  157. Mulik, 2009, Development of curcuminoids loaded poly (butyl) cyanoacrylate nanoparticles: physicochemical characterization and stability study, Eur. J. Pharm. Sci., 37, 395, 10.1016/j.ejps.2009.03.009 · DOI
  158. Müller, 2002, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations, Adv. Drug Deliv. Rev., 54, S131, 10.1016/S0169-409X(02)00118-7 · DOI
  159. Müller, 2002, Nanostructured lipid matrices for improved microencapsulation of drugs, Int. J. Pharm., 242, 121, 10.1016/S0378-5173(02)00180-1 · DOI
  160. Muppidi, 2012, Development and stability studies of novel liposomal vancomycin formulations, ISRN Pharmaceutics, 1, 10.5402/2012/636743 · DOI
  161. Muthu, 2009, Poly (D, L-lactide) nanosuspensions of risperidone for parenteral delivery: formulation and in vitro evaluation, Curr. Drug Deliv., 6, 62, 10.2174/156720109787048302 · DOI
  162. Naegel, 2013, Detailed modeling of skin penetration—an overview, Adv. Drug Deliv., 65, 191, 10.1016/j.addr.2012.10.009 · DOI
  163. Nair, 2013, Basic considerations in the dermatokinetics of topical formulations, Braz. J. Pharm. Sci., 49, 423, 10.1590/S1984-82502013000300004 · DOI
  164. Narayanan, 2010, Ultraviolet radiation and skin cancer, Int. J. Dermatol., 49, 978, 10.1111/j.1365-4632.2010.04474.x · DOI
  165. Neagu, 2016, Chemically induced skin carcinogenesis: updates in experimental models (review), Oncol. Rep., 35, 2516, 10.3892/or.2016.4683 · DOI
  166. Nikolaou, 2014, Emerging trends in the epidemiology of melanoma, Br. J. Dermatol., 170, 11, 10.1111/bjd.12492 · DOI
  167. Nikolaou, 2012, Melanoma: new insights and new therapies, J. Invest. Dermatol., 132, 854, 10.1038/jid.2011.421 · DOI
  168. Ning, 2005, Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole, Drug Dev. Ind. Pharm., 31, 375, 10.1081/DDC-54315 · DOI
  169. Norval, 2011, The human health effects of ozone depletion and interactions with climate change, Photochem. Photobiol. Sci., 10, 199, 10.1039/c0pp90044c · DOI
  170. Obeidat, 2010, Preservation of nanostructured lipid carriers (NLC), Eur. J. Pharm. Biopharm., 76, 56, 10.1016/j.ejpb.2010.05.001 · DOI
  171. O'Driscoll, 2006, Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays, Mol. Cancer, 5, 74, 10.1186/1476-4598-5-74 · DOI
  172. Ourique, 2011, Improved photostability and reduced skin permeation of tretinoin: development of a semisolid nanomedicine, Eur. J. Pharm. Biopharm., 79, 95, 10.1016/j.ejpb.2011.03.008 · DOI · Paper page
  173. Padamwar, 2006, Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability, Int. J. Pharm., 320, 37, 10.1016/j.ijpharm.2006.04.001 · DOI
  174. Pallerla, 2013, A review on solid lipid nanoparticles, Int. J. Pharm. Sci. Rev. Res., 20, 196
  175. Pandey, 2010, Pluronic lecithin organogel as a topical drug delivery system, Drug Deliv., 17, 38, 10.3109/10717540903508961 · DOI
  176. Pandey, 2013, An overview on transdermal drug delivery system, Int. J. Pharm. Chem. Sci., 2, 1171
  177. Pandit, 2014, Miconazole nitrate bearing ultraflexible liposomes for the treatment of fungal infection, J. Liposome Res., 24, 163, 10.3109/08982104.2013.871025 · DOI
  178. Pappinen, 2012, Organotypic cell cultures and two-photon imaging: tools for in vitro and in vivo assessment of percutaneous drug delivery and skin toxicity, J. Control. Release, 161, 656, 10.1016/j.jconrel.2012.03.005 · DOI
  179. Pardeike, 2009, Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products, Int. J. Pharm., 366, 170, 10.1016/j.ijpharm.2008.10.003 · DOI · Paper page
  180. Park, 2010, Assessment of dermal toxicity of nanosilica using cultured keratinocytes, a human skin equivalent model and an in vivo model, Toxicology, 267, 178, 10.1016/j.tox.2009.10.011 · DOI
  181. Patel, 2013, Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo: ex vivo permeation and skin irritation studies, Coll. Surf. B: Biointerfaces, 102, 86, 10.1016/j.colsurfb.2012.08.011 · DOI
  182. Paudel, 2010, Challenges and opportunities in dermal/transdermal delivery, Ther. Deliv., 1, 109, 10.4155/tde.10.16 · DOI
  183. Pavelic, 2001, Liposomal gels for vaginal drug delivery, Int. J. Pharm., 219, 139, 10.1016/S0378-5173(01)00637-8 · DOI
  184. Pazourekova, 2013, Dermal absorption and hydrolysis of methylparaben in different vehicles through intact and damaged skin: using a pig-ear model in vitro, Food Chem. Toxicol., 59, 754, 10.1016/j.fct.2013.07.025 · DOI
  185. Peira, 2014, The influence of surface charge and photo-reactivity on skin-permeation enhancer property of nano-TiO2 in ex vivo pig skin model under indoor light, Int. J. Pharm., 467, 90, 10.1016/j.ijpharm.2014.03.052 · DOI
  186. Pepe, 2013, Protein transduction domain-containing microemulsions as cutaneous delivery systems for an anticancer agent, J. Pharm. Sci., 102, 1476, 10.1002/jps.23482 · DOI
  187. Plessis, 1992, Topical delivery of liposomally encapsulated gamma-interferon, Antivir Res., 18, 259, 10.1016/0166-3542(92)90059-E · DOI
  188. Ponec, 2002, Skin constructs for replacements of skin tissues for in vitro testing, Adv. Drug Deliv. Rev., 54, S19, 10.1016/S0169-409X(02)00112-6 · DOI
  189. Ponec, 1997, The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C, J. Invest. Dermatol., 109, 348, 10.1111/1523-1747.ep12336024 · DOI · Paper page
  190. Pople, 2013, Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, Part II—in vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis, Eur. J. Pharm. Biopharm., 84, 72, 10.1016/j.ejpb.2012.11.026 · DOI
  191. Porter, 2013, Recent advances in lipid-based formulation technology, Pharm. Res., 30, 2971, 10.1007/s11095-013-1229-7 · DOI
  192. Prasad, 2014, Ultraviolet radiation-induced inflammation activates β-catenin signaling in mouse skin and skin tumors, Int. J. Oncol., 44, 1199, 10.3892/ijo.2014.2275 · DOI
  193. Primo, 2008, Photophysical studies and in vitro skin permeation/retention of Foscan/nanoemulsion (NE) applicable to photodynamic therapy skin cancer treatment, J. Nanosci. Nanotechnol., 8, 340, 10.1166/jnn.2008.18137 · DOI
  194. Prow, 2011, Nanoparticles and microparticles for skin drug delivery, Adv. Drug Deliv. Rev., 63, 470, 10.1016/j.addr.2011.01.012 · DOI
  195. Puglia, 2012, Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals, Expert Opin. Drug Deliv., 9, 429, 10.1517/17425247.2012.666967 · DOI
  196. Pyatski, 2016, Effects of permeation enhancers on flufenamic acid delivery in ex vivo human skin by confocal Raman microscopy, Int. J. Pharm., 505, 319, 10.1016/j.ijpharm.2016.04.011 · DOI
  197. Qiu, 2008, Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes, J. Control. Release, 129, 144, 10.1016/j.jconrel.2008.04.019 · DOI
  198. Queille-Roussel, 2001, Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel, Clin. Ther., 23, 205, 10.1016/S0149-2918(01)80003-5 · DOI
  199. Raaf, 1976, Treatment of Bowen’s disease with topical dinitrochlorobenzene and 5-fluorouracil, Cancer, 37, 1633, 10.1002/1097-0142(197604)37:4<1633::AID-CNCR2820370403>3.0.CO;2-P · DOI
  200. Raber, 2014, Quantification of nanoparticle uptake into hair follicles in pig ear and human fore arm, J. Control. Release, 179, 25, 10.1016/j.jconrel.2014.01.018 · DOI

200 of 253 shown

Cited by

Sorted by citations

See all 96

Metadata

Authors
Gupta, V., & Trivedi, P.
Affiliations
  • Department of Science and Technology (IN)
  • Rajiv Gandhi Technical University (IN)
ORCID
Venue
Lipid Nanocarriers for Drug Targeting
Publisher
Elsevier
Published
2018
Pages
563-627
DOI
10.1016/b978-0-12-813687-4.00015-3
OpenAlex
W2800876213
Cited by
96
References
5
Citations by year
2026: 7 · 2025: 14 · 2024: 30 · 2023: 14 · 2022: 18 · 2021: 6 · 2020: 5 · 2019: 1
FWCI
3.37
Type
book chapter
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
Elsevier eBooks (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
skin cancer, dermal drug delivery, lipid-based nanocarriers, polymer-based nanocarriers, nanoemulsions, nanogels, anticancer agents, skin permeation, skin retention, xenografts, tissue distribution, pharmacokinetics, skin irritation, encapsulation efficiency, drug stability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review